Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Neoplasms 3Neoplasm Metastasis 1Adolescent Behavior 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Aging × 1 year × Clear all
NCT07011862 2026-04-24

COBRA: Cancer, Older Adults, Balance and Resistance Activities

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
38 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT06824441 2026-03-12

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

Stanford University

Phase NA Active not recruiting
83 enrolled

Adolescent Behavior, Neoplasms

NCT00505063 2025-06-15

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
76 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡